CLINICAL TRIALS PROFILE FOR EVZIO (AUTOINJECTOR)
✉ Email this page to a colleague
All Clinical Trials for EVZIO (AUTOINJECTOR)
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00534378 ↗ | Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector | Completed | U.S. Army Office of the Surgeon General | Phase 1 | 2006-07-01 | Purpose of the study is to determine midazolam's safety and dose-linearity when delivered intramuscularly via an autoinjector. The proposed initial treatment dosage for seizures induced by exposure to nerve agents. |
| NCT00809146 ↗ | Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications | Completed | Medical University of South Carolina | Phase 3 | 2009-06-01 | The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing. |
| NCT00809146 ↗ | Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 3 | 2009-06-01 | The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing. |
| NCT00809146 ↗ | Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications | Completed | University of California, San Francisco | Phase 3 | 2009-06-01 | The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing. |
| NCT00809146 ↗ | Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications | Completed | Robert Silbergleit | Phase 3 | 2009-06-01 | The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing. |
| NCT00828204 ↗ | Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects | Completed | Biogen | Phase 3 | 2009-01-01 | The primary objective of the study was to evaluate the safe and effective use of the single-use autoinjector for the intramuscular (IM) delivery of liquid Avonex® (interferon beta-1a) in participants with multiple sclerosis (MS). |
| NCT00915577 ↗ | Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe | Completed | Biogen | Phase 3 | 2005-08-01 | Determine patient satisfaction with the single-use autoinjector for the delivery of pre-filled Avonex syringe. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for EVZIO (AUTOINJECTOR)
Condition Name
Clinical Trial Locations for EVZIO (AUTOINJECTOR)
Trials by Country
Clinical Trial Progress for EVZIO (AUTOINJECTOR)
Clinical Trial Phase
Clinical Trial Sponsors for EVZIO (AUTOINJECTOR)
Sponsor Name
